\clan {Rok Hren}

%--------------------------------------------------------
%  A. objavljene znanstvene monografije
%--------------------------------------------------------

%\begin{skupina}{A}

%\disertacija
%   {NASLOV}
%   {UNIVERZA}
%   {FAKULTETA}
%   {ODDELEK}
%   {KRAJ} {DRZAVA} {LETO} 

%\magisterij
%   {NASLOV}
%   {UNIVERZA}
%   {FAKULTETA}
%   {ODDELEK}
%   {KRAJ} {DRZAVA} {LETO} 

%\monografija
%   {AVTORJI}
%   {NASLOV}
%   {ZALOZBA}
%   {KRAJ} {DRZAVA} {LETO} 

%\end{skupina} 

%   Ni podatkov za to sekcijo

%--------------------------------------------------------
%  B. raziskovalni clanki sprejeti v objavo v znanstvenih
%     revijah in v zbornikih konferenc
%--------------------------------------------------------

%\begin{skupina}{B}

%\sprejetoRevija
%   {AVTORJI}
%   {NASLOV}
%   {REVIJA}
%\sprejetoZbornik
%   {AVTORJI}
%   {NASLOV}
%   {KONFERENCA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO} 

%\end{skupina} 


%   Ni podatkov za to sekcijo

%--------------------------------------------------------
%  C. raziskovalni clanki objavljeni v znanstvenih revijah
%     in v zbornikih konferenc
%--------------------------------------------------------

%\begin{skupina}{C}

%\objavljenoRevija
%   {AVTORJI}
%   {NASLOV}
%   {REVIJA} {LETNIK} {LETO} {STEVILKA} {STRANI}
%\objavljenoZbornik
%   {AVTORJI}
%   {NASLOV}
%   {KONFERENCA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO} 

%   {ZBORNIK} {STRANI} 

%\end{skupina} 

%   Ni podatkov za to sekcijo

%--------------------------------------------------------
%  D. urednistvo v znanstvenih revijah in zbornikih
%     znanstvenih konferenc
%--------------------------------------------------------

%\begin{skupina}{D}

%\urednikRevija
%   {OPIS}
%   {REVIJA}
%\urednikZbornik
%   {OPIS}
%   {KONFERENCA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO} 

%\end{skupina} 

%    Ni podatkov za to sekcijo

%--------------------------------------------------------
%  E. organizacija mednarodnih in domacih znanstvenih 
%     srecanj
%--------------------------------------------------------

%\begin{skupina}{E}

%\organizacija
%   {OPIS}
%   {KONFERENCA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO} 

%\end{skupina} 

%   Ni podatkov za to sekcijo

%--------------------------------------------------------
%  F. vabljena predavanja na tujih ustanovah in 
%     mednarodnih konferencah
%--------------------------------------------------------

%\begin{skupina}{F}

%\predavanjeUstanova
%   {NASLOV}
%   {OPIS}
%   {USTANOVA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO}
%\predavanjeKonferenca
%   {NASLOV}
%   {OPIS}
%   {KONFERENCA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO} 

%\end{skupina}
 
\begin{skupina}{F}

%�    Hren R. ISPOR Health Science Policy Council support to the ISPOR community and its research activities in the region. Invited presentation at the 8th Adriatic and 5th ISPOR Chapter Serbia Congress of Pharmacoeconomics and Outcomes Research, Belgrade, Serbia, April 19, 2017.
\predavanjeKonferenca
   {ISPOR Health Science Policy Council support to the ISPOR community and its research activities in the region}
   {vabljeno predavanje}
   {8\uth Adriatic and 5\uth ISPOR Chapter Serbia Congress of Pharmacoeconomics and Outcomes Research}
   {Beograd} {Srbija} {april} {2018} 

%�    Hren R. Access to innovation and reimbursement � experience in Slovenia. Invited lecture at the Innovation Forum: With Innovation to a Healthy Nation. Skopje, May 31, 2018. 
\predavanjeKonferenca
   {Access to innovation and reimbursement � experience in Slovenia}
   {vabljeno predavanje}
   {Innovation Forum: With Innovation to a Healthy Nation}
   {Skopje} {Makedonija} {maj} {2018} 

%�    Hren R. Challenges in pharmaceutical HTA and reimbursement processes. Invited presentation at the Croatian-Slovenian Symposium of Pharmacoeconomics and Outcomes Research �Patient Access to Medical Innovation � Regional Challenges and Initiatives�, Opatija, Croatia, September 18, 2018.
\predavanjeKonferenca
   {Challenges in pharmaceutical HTA and reimbursement processes}
   {vabljeno predavanje}
   {Patient Access to Medical Innovation � Regional Challenges and Initiatives}
   {Opatija} {Hrva�ka} {september} {2018} 

%�    Hren R. Performance based model kao alat za unapredjenje dostupnosti inovativnih lekova (in Serbian). Invited presentation at the meeting �Mogu�nosti za unapredjenje dostupnosti inovacija i ishoda le�enja u karcinomu plu�a�, Belgrade, Serbia, November 11, 2018.
\predavanjeKonferenca
   {Performance based model kao alat za unapredjenje dostupnosti inovativnih lekova (in Serbian)}
   {vabljeno predavanje}
   {Mogu�nosti za una\-pre\-dje\-nje dostupnosti inovacija i ishoda le�enja u karcinomu plu�a}
   {Beograd} {Srbija} {november} {2018} 

%�    Hren R. Modeli finansiranja lekova zasnovani na ishodima le�enja (in Serbian). Vabljeno predavanje na kongresu �55. Kancerolo�ka nedelja i 32. Simpozijum medicinskih sestara-tehni�ara onkolo�kih institucija Republike Srbije�, Belgrade, Serbia, October 31 � November 3, 2018. 
\predavanjeKonferenca
   {Modeli finansiranja lekova zasnovani na ishodima le�enja}
   {vabljeno predavanje}
   {55. Kancerolo�ka nedelja i 32. Simpozijum medicinskih sestara-tehni�ara onkolo�kih institucija Republike Srbije}
   {Beograd} {Srbija} {november} {2018} 

\end{skupina} 

%--------------------------------------------------------
%  G. aktivne udelezbe na mednarodnih in domacih
%     konferencah
%--------------------------------------------------------

%\begin{skupina}{G}

%\konferenca
%   {NASLOV}
%   {KONFERENCA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO} 

%\end{skupina} 


\begin{skupina}{G}

%�    Navarro F, Hren R, Boltyenkov A. Budget impact analysis of point-of-care HbA1c monitoring in Belgian, German and Swiss patients with diabetes mellitus type II. Poster presented at the ISPOR 21st Annual International Meeting, May 19-23, 2018.
\konferenca
   {Budget impact analysis of point-of-care HbA1c monitoring in Belgian, German and Swiss patients with diabetes mellitus type II}
   {ISPOR 21\ust An\-nu\-al International Meeting}
   {Baltimore} {ZDA} {maj} {2018} 

%�    Navarro F, Hren R, Boltyenkov A. Health economics analysis of point-of-care HbA1c monitoring in Belgian, German and Swiss patients with diabetes mellitus type II. Poster presented at the American Diabetes Association�s 78th Scientific Sessions, June 22-26, 2018.
\konferenca
   {Health economics analysis of point-of-care HbA1c monitoring in Belgian, German and Swiss patients with diabetes mellitus type II}
   {American Diabetes Association�s 78\uth Scientific Sessions}
   {Orlando} {ZDA} {junij} {2018} 

%�    Navarro F, Hren R, Boltyenkov A. The importance of health economics modeling in assessing costs of point-of-care HbA1c testing of patients with diabetes mellitus type II in the United States. Poster presented at the 70th AACC Annual Scientific Meeting & Clinical Lab Expo, Chicago, July 29-August 2, 2018. 
\konferenca
   {The importance of health economics modeling in assessing costs of point-of-care HbA1c testing of patients with diabetes mellitus type II in the United States}
   {70\uth AACC Annual Scientific Meeting \& Clinical Lab Expo}
   {Chicago} {ZDA} {avgust} {2018} 

%�    Hren R, Milanic M, Jerabkova M, Kajtor Z. Cost-effectiveness analysis of apremilast in the treatment of psoriatic arthritis (PsA) in Slovak Republic and Slovenia. Poster presentation at the ISPOR 21st Annual European Congress, Barcelona, November 10-14, 2018.
\konferenca
   {Cost-effectiveness analysis of apremilast in the treatment of psoriatic arthritis (PsA) in Slovak Republic and Slovenia}
   {ISPOR 21\ust Annual European Congress}
   {Barcelona} {�panija} {november} {218} 

%�    Hren R, Olbrecht J, Vidmar A, Plevnik Kapun A.  Pharmacoeconomic evaluation of public procurement criteria in the national pneumococcal vaccine immunization program: Slovenia as a case study. Poster presentation at the ISPOR 21st Annual European Congress, Barcelona, November 10-14, 2018.
\konferenca
   {Pharmacoeconomic evaluation of public procurement criteria in the national pneumococcal vaccine immunization program: Slovenia as a case study}
   {ISPOR 21\ust Annual European Congress}
   {Barcelona} {�panija} {november} {218} 

%�    Navarro F, Hren R, Boltyenkov A. Budget impact modelling of point-of-care HbA1c monitoring of patients with diabetes mellitus type type II in the United Kingdom and Australia. Poster presentation at the ISPOR 21st Annual European Congress, Barcelona, November 10-14, 2018.
\konferenca
   {Budget impact modelling of point-of-care HbA1c monitoring of patients with diabetes mellitus type type II in the United Kingdom and Australia}
   {ISPOR 21\ust Annual European Congress}
   {Barcelona} {�panija} {november} {218} 

\end{skupina} 

%--------------------------------------------------------
%  H. strokovni clanki
%--------------------------------------------------------

%\begin{skupina}{H}

%\clanekRevija
%   {AVTORJI}
%   {NASLOV}
%   {REVIJA} {LETNIK} {LETO} {STEVILKA} {STRANI}
%\clanekZbornik
%   {AVTORJI}
%   {NASLOV}
%   {KONFERENCA}
%   {KRAJ} {DRZAVA} {MESEC} {LETO}
%   {ZBORNIK} {STRANI} 

%\end{skupina} 

%   Ni podatkov za to sekcijo

%--------------------------------------------------------
%  I. razno
%--------------------------------------------------------

%\begin{skupina}{I}

%\razno
%   {OPIS} 

%\end{skupina} 

\begin{skupina}{I}

%\razno
%   {OPIS} 
%Poleg tega sem:
%- imel 3-urno delavnico (v srbskem jeziku) "Vrijednost i dostupnost inovacija� za �lane AmCham, Ministrstva za zdravstvo Republike �rne Gore ter Zavoda za zdravstveno %zavarovanje �rne Gore v Podgorici, �rna Gora 26. oktobra 2018.
\razno 
{3-urna delavnica (v srbskem jeziku) "Vrijednost i dostupnost inovacija� za �lane AmCham, Ministrstva za zdravstvo Republike �rne Gore ter Zavoda za zdravstveno zavarovanje �rne Gore v Podgorici, �rna Gora, oktober 2018}
%- bil eden izmed treh predavateljev 4-urne delavnice ISPOR Short Course Program "Risk-Sharing/Performance-Based Arrangements in Central & Eastern Europe: Implementation of %Managed Entry Agreements", ISPOR 21st Annual European Congress, 2018. 
\razno
{Eden izmed treh predavateljev 4-urne delavnice ISPOR Short Course Program ``Risk-Sharing/Performance-Based Arrangements in Central \& Eastern Europe: Implementation of Managed Entry Agreement'', ISPOR 21\ust Annual European Congress, 2018}
%- bil moderator sekcije Priority setting - criteria and processes of rare diseases management in CEE Countries at the ISPOR 21st Annual European Congress, Barcelona, November %10-14, 2018.
\razno
{Moderator sekcije Priority setting - criteria and processes of rare diseases management in CEE Countries at the ISPOR 21\ust Annual European Congress, Barcelona, november, 2018}
%
%Od 1. julija 2018 sem �lan Upravnega odbora (Board of Directors) neprofitne organizacije ISPOR - The Professional Society for Health Economics and Outcomes Research 
\razno
{�lan upravnega odbora (Board of Directors) neprofitne organizacije ISPOR - The Professional Society for Health Economics and Outcomes Research}
%
%Sem �lan Health Policy and Science Council (HSPC) neprofitne organizacije ISPOR - The Professional Society for Health Economics and Outcomes Research 
\razno
{�lan Health Policy and Science Council (HSPC) neprofitne organizacije ISPOR - The Professional Society for Health Economics and Outcomes Research}

\end{skupina} 

%--------------------------------------------------------
%  tuji gosti
%--------------------------------------------------------

%\begin{seznam}
%\gost {IME} {TRAJANJE} {USTANOVA} {KRAJ} {DRZAVA} {MESEC} {LETO} {POVABILO}
%\end{seznam} 

%--------------------------------------------------------
%  gostovanja
%--------------------------------------------------------

%\begin{seznam}
%\gostovanje {IME} {TRAJANJE} {USTANOVA} {KRAJ} {DRZAVA} {MESEC} {LETO}
%\end{seznam} 

